Friday, 18 Aug 2017

You are here

Increased Pulmonary Embolism Risk in Lupus Patients

Systemic lupus erythematosus (SLE) poses numerous vascular risks, many of which are thought to be autoantibody mediated.

A retrospective population-based analysis was done to determine the association of SLE and plumonary embolism (PE) using the National Hospital Discharge Survey data, a representative sample of hospital discharges throughout the United States.

Researchers identified PE cases for the period 2001 to 2010. Among those were identified as SLE (ICD-9 code 710.0) and PE (ICD-9 codes 415.11, 415.12, 415.13, and 415.19).

A significant association between SLE and PE, independent of sex, race, age, comorbidities, found a two-fold increase risk of PE (odds ratio [OR], 2.0; 95% confidence interval [CI], 1.99–2.16).

Patients with a primary hypercoagulable disorder had the greatest odds of PE (OR, 15.37; 95% CI, 15.22–15.51). A higher risk was seen in those of African American (AA) race (OR, 1.08, 95% 1.08–1.09), and presence of at least 1 of the comorbidities (OR, 1.06; 95% CI, 1.06–1.06).

Females, especially AA, had an overall higher prevalence of SLE-related PE (1.67%) compared with males (1.29%). This PE-SLE association was highest for females, blacks, and age group 35 to 44 years, respectively.

Disclosures: 
The author has no conflicts of interest to disclose related to this subject

Add new comment

More Like This

Duration of Azathioprine Maintenance in AAV Does Not Alter Relapse Rates

A European multicentre study examined whether the duration of azathioprine (AZA) maintenance therapy in ANCA-associated vasculitis patients would influence the relapse rate during long-term follow-up.

Mycophenolate and Steroids in Neuropsychiatric Lupus

Beyond diagnosis, management of neuropsychiatric lupus (NPSLE) can be challenging. Moreover, there are scant studies addressing optimal management. In this issue of Clinical Rheumatology, researchers show the efficacy of mycophenolate mofetil (MMF) and deflazacort in NPSLE.

H1N1 Vaccination Triggers TLR Activation and Autoantibody Production in DMARD-naïve pSS

Increased morbidity and mortality from infectious causes in patients with autoimmune disorders has led to the overall consensus that vaccination of such patients is important and should be widely promoted in clinical practice. However, the autoimmune-biased immune system of the patient with rheumatic disease and use of immunosuppressive drugs tend to affect response to vaccination.

Lupus Hospitalizations are Common

Patients with systemic lupus erythematosus (SLE) incur substantial morbidity and complications that may lead to hospitalizations and increased cost of lupus care. Researchers from the University Health Network in Toronto have published a review of SLE hospitalizations showing thta while commone (for either infection or lupus activity), only 2.8% of hospitalizations resulted in death.

Tubulointerstitial Damage in Lupus Predicts ESRD Progression

The presence of tubulointerstitial damage (TID) may provide a potential window for early intervention in lupus nephritis (LN) to ward off end-stage renal disease (ESRD), according to a data analysis.